Whetstone Capital Advisors’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,562,001
Closed -$10.1M 30
2021
Q4
$10.1M Buy
6,562,001
+1,282,784
+24% +$2.12M 2.07% 16
2021
Q3
$8.29M Sell
5,279,217
-9,204
-0.2% -$18K 1.45% 22
2021
Q2
$13.9M Sell
5,288,421
-2,440
-0% -$4.54K 2.58% 18
2021
Q1
$7.99M Sell
5,290,861
-46,837
-0.9% -$81.2K 1.69% 21
2020
Q4
$6.94M Buy
5,337,698
+263,578
+5% +$296K 1.43% 19
2020
Q3
$5.73M Buy
5,074,120
+1,906,856
+60% +$2.1M 1.06% 24
2020
Q2
$2.63M Buy
+3,167,264
New +$2.35M 0.55% 27

Whetstone Capital Advisors's CSLT Position: Q1 2022 in Review

Whetstone Capital Advisors sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 6,562,001 shares — an estimated $10.1M sold.

Whetstone Capital Advisors first reported a position in CSLT in Q2 2020 and held it in 7 quarters. The position peaked at $13.9M in Q2 2021. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.

  • Whetstone Capital Advisors reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
  • Whetstone Capital Advisors sold 6,562,001 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $10.1M.
  • Whetstone Capital Advisors first reported a position in CASTLIGHT HEALTH, INC. in Q2 2020 and held it in 7 quarters.
  • Whetstone Capital Advisors's CASTLIGHT HEALTH, INC. position peaked at $13.9M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.

Based on Whetstone Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.